Cyclosporin and the gingival tissues
- 1 January 1992
- journal article
- Published by Wiley in Journal of Clinical Periodontology
- Vol. 19 (1) , 1-11
- https://doi.org/10.1111/j.1600-051x.1992.tb01140.x
Abstract
Cyclosporin is a selective immunosuppressant that has a variety of applications in medical practice. Like phenytoin and the calcium channel blockers, the drug is associated with gingival overgrowth. This review considers the pharmacokinetics, pharmacodynamics, uses and unwanted effects of Cyclosporin, in particular the action of the drug on the gingival tissues. Clinical and cell culture studies suggest that the mechanism of gingival overgrowth is a result of an interaction between the drug and its metabolites with susceptible gingival fibro‐blasts. Plaque‐induced gingival inflammation appears to enhance this interaction.Keywords
This publication has 69 references indexed in Scilit:
- Preliminary Results of a Double-Blind, Randomized, Placebo-Controlled Trial of Cyclosporine in Myasthenia GravisNew England Journal of Medicine, 1987
- Cyclosporine in Refractory Severe Aplastic AnemiaNew England Journal of Medicine, 1985
- REVERSIBILITY OF CYCLOSPORIN NEPHROTOXICITY AFTER THREE MONTHS' TREATMENTThe Lancet, 1985
- Cyclosporine in Refractory Severe Aplastic AnemiaNew England Journal of Medicine, 1984
- A Randomized Clinical Trial of Cyclosporine in Cadaveric Renal TransplantationNew England Journal of Medicine, 1983
- Cyclosporine for Treatment of Early Type I Diabetes: Preliminary ResultsNew England Journal of Medicine, 1983
- Antimalarial activity of cyclosporin AInflammation Research, 1981
- Antischistosomal effects of cyclosporin AInflammation Research, 1981
- Cyclosporin Relieves Arthralgia, Causes AngioedemaNew England Journal of Medicine, 1980
- CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATIONThe Lancet, 1980